Press Releases (Page 165)

Extendicare Announces April 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of April 2024, which is payable on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the... ❯❯❯

Ontario Psychological Association Unveils New Mental Health Insights - Report

TORONTO, April 12, 2024 (GLOBE NEWSWIRE) -- The Ontario Psychological Association (OPA) today released a pivotal report, “Mental Health in Ontario: Insights from AskForHelpToday.ca,” based on an analysis of over 12,000 referrals since the platform's inception in 2021. This comprehensive document offers an unprecedented look into the mental health demands and the evolving role of digital health in addressing these needs. Key... ❯❯❯

RadNet Teams Up with Basketball Icon Sheryl Swoopes to Promote Healthcare Equity and Access

First Initiative Spotlights Breast Cancer Screening Services Inside WalmartLOS ANGELES, April 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announced that basketball legend and WNBA superstar Sheryl Swoopes will be a spokesperson for its nationwide cancer screening programs. Swoopes will emphasize the need for more... ❯❯❯

RadNet Announces Pricing and Upsizing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing Transaction

LOS ANGELES, April 11, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today announced that it has completed pricing and allocations for the proposed refinancing of its existing term loan. On April 3, 2024, RadNet announced its intention to refinance debt facilities that, at December 31, 2023, included a $679... ❯❯❯

University Cancer & Blood Center and University Health Alliance open High-Risk GI Clinic to address community needs

State-of-the-art program features acclaimed physicians and experts in oncology and gastroenterologyATHENS, Ga., April 10, 2024 (GLOBE NEWSWIRE) -- University Cancer & Blood Center (UCBC), a leading oncology and hematology practice for Northeast Georgia, and University Health Alliance (UHA), a multi-disciplinary practice focusing on prevention and coordinated care, announce the opening of their High-Risk GI Clinic. The facility allows... ❯❯❯

RadNet to Make its Second Acquisition in Houston, Texas

LOS ANGELES, April 10, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announces that it has signed a definitive agreement to purchase the assets of six imaging centers in the greater Houston, Texas metropolitan area. This acquisition, which is anticipated to be completed before the end of the second quarter of 2024, is... ❯❯❯

Olansky Dermatology & Aesthetics welcomes physician assistant, expands hours

Addition of Kathryn “Katie” Shea, PA-C allows Olansky Dermatology & Aesthetics to offer extended hours at Buckhead locationATLANTA, April 09, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– welcomes physician assistant Kathryn “Katie” Shea to its Buckhead location. This addition to the practice’s acclaimed staff allows Olansky Dermatology & Aesthetics the ability to offer new,... ❯❯❯

Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by Metabolic Dysfunction-Associated SteatoHepatitis

Data and Safety Monitoring Board (DSMB) recommends the continuation, without modifications, of the adaptive Phase 2b/3 NAVIGATE study of belapectin in metabolic dysfunction-associated steatohepatitis (MASH) liver cirrhosisFifth positive recommendation further supports favorable tolerability and safety profile of belapectinInterim Phase 2b efficacy readout anticipated in Q4 2024 NORCROSS, Ga., April 09, 2024 (GLOBE... ❯❯❯

Option Care Health to Announce First Quarter 2024 Financial Results and Host Conference Call

BANNOCKBURN, Ill., April 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2024 on Tuesday, April 23, 2024 before the market opens. In conjunction, the management team will host a conference call to review the... ❯❯❯

Allarity Therapeutics Announces 1-for-20 Reverse Stock Split

Boston (April 4, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the implementation of a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20 (the “Reverse Stock Split”). The Reverse Stock Split will become effective at 9:30 a.m. Eastern Time on April 9, 2024.... ❯❯❯